Press Release
Category Added in a WPeMatico Campaign
-
Cision PR Newswire3 September 2025American Bitcoin Debuts on Nasdaq as “ABTC”
Differentiated, pure-play Bitcoin accumulation platform is purpose-built to drive Bitcoin-per-share growth with leading scale and efficiency MIAMI, Sept. 3, 2025…
Read More » -
Cision PR Newswire3 September 2025Trulieve Wins Seven Brandon Hall Group Awards for Excellence in Employee Development
Recognized for innovative learning, development, and talent management programs TALLAHASSEE, Fla., Sept. 3, 2025 /PRNewswire/ — Trulieve Cannabis Corp. (CSE:…
Read More » -
Cision PR Newswire3 September 2025Bandwidth to Reveal New AI and Trust Innovations At Reverb25 on Sept. 16, With Registration Now Open
Award-winning livestream returns Sept. 16 at 10:30 am EDT with exclusive insights and announcements from Bandwidth leaders and special guests…
Read More » -
Cision PR Newswire3 September 2025Nanalysis Chosen by IMRIS as Critical Component MRI Supplier
CALGARY, AB, Sept. 3, 2025 /PRNewswire/ – Nanalysis Scientific Corp. (“the Company”) (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in…
Read More » -
Business Wire3 September 2025
Transcat to Participate in the D.A. Davidson 24th Annual Diversified Industrials & Services Conference on September 18
ROCHESTER, N.Y.–(BUSINESS WIRE)–Transcat, Inc. (NASDAQ: TRNS) (“Transcat” or the “Company”), a leader in test measurement, control and calibration, will participate…
Read More » -
Business Wire3 September 2025
Ori Biotech’s IRO® Platform Receives FDA Advanced Manufacturing Technology (AMT) Designation
AMT designation provides developers using IRO with earlier and more frequent FDA engagement, accelerating regulatory filings and patient access PHILADELPHIA…
Read More » -
Business Wire3 September 2025
Genmab Announces Updated Results from Phase 2 EPCORE® NHL-6 Study Evaluating Epcoritamab Monotherapy in the Outpatient Setting in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
Trial demonstrated the feasibility of treating and monitoring adult patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) in an…
Read More » -
Business Wire3 September 2025
CSG Systems International to Hold Third Quarter 2025 Earnings Conference Call on November 5
DENVER–(BUSINESS WIRE)–CSG® (NASDAQ: CSGS) invites you to participate in a conference call on Wednesday, November 5, 2025, at 5:00 p.m.…
Read More » -
Business Wire3 September 2025
CyberArk Named Leader and Outperformer in GigaOm Radar for Enterprise Password Management
Report underscores CyberArk’s identity security leadership and innovative product capabilities NEWTON, Mass. & PETACH TIKVA, Israel–(BUSINESS WIRE)–CyberArk (NASDAQ: CYBR), the…
Read More » -
Cision PR Newswire3 September 2025TRUE RX HEALTH STRATEGISTS LAUNCHES NEW MOBILE APP, True Rx+™
App helps patients manage pharmacy benefits, compare medication prices, and live chat with a Health Strategist INDIANAPOLIS, Sept. 3, 2025…
Read More »